Safety and Efficacy of Sofosbuvir + Velpatasvir With or Without Ribavirin in Treatment-Naive Adults With Chronic HCV Infection

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The primary objectives of this study are to evaluate the antiviral efficacy, safety, and tolerability of sofosbuvir (SOF) + velpatasvir (VEL; GS-5816) with or without ribavirin (RBV) in treatment-naive adults with chronic genotype (GT) 1, 2, 3, 4, 5, or 6 hepatitis C virus (HCV) infection.
Epistemonikos ID: d5bffdc7d2f1d5e9528ae65ec79c814d5c2de3c7
First added on: May 11, 2024